World Library  
Flag as Inappropriate
Email this Article

Porfimer sodium

Article Id: WHEBN0006607951
Reproduction Date:

Title: Porfimer sodium  
Author: World Heritage Encyclopedia
Language: English
Subject: List of drugs: Pj-Pra, Chemotherapy, Cell-cycle nonspecific antineoplastic agents, Hazardous drugs, Thiopurine
Collection: Photosensitizing Agents
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Porfimer sodium

Porfimer sodium
Clinical data
AHFS/Drugs.com
Licence data EMA:, US FDA:
Pregnancy
category
  • US: C (Risk not ruled out)
Legal status
Routes of
administration
Intravenous
Pharmacokinetic data
Bioavailability NA
Protein binding ~90%
Biological half-life 21.5 days (mean)
Excretion Fecal
Identifiers
CAS Registry Number  N 87806-31-3
ATC code L01
PubChem CID:
DrugBank  N
ChemSpider  Y
UNII  N
ChEMBL  N
Chemical data
Formula C68H74N8O11 (for n=0)
Molecular mass 1179.36 g/mol (for n=0)
 N   

Porfimer sodium, sold as Photofrin, is a photosensitizer used in photodynamic therapy and radiation therapy and for palliative treatment of obstructing endobronchial non-small cell lung carcinoma and obstructing esophageal cancer.

Porfimer is a mixture of oligomers formed by ether and ester linkages of up to eight porphyrin units.[1] In practice, a red light source emitting at 630 nm is used to excite the Porfimer oligomers.[2]

Porfimer is Haematoporphyrin Derivative (HpD) (See PDT).

Approvals and indications

It was approved in Canada in 1993 for the treatment of bladder cancer.[2] It was approved in Japan in 1994 (for early stage lung cancer?).[2] It was approved by the U.S. FDA in December 1995 for esophageal cancer, and in 1998, it was approved for the treatment of early non-small cell lung cancer.[2]

In August 2003 the FDA approved its use for Barrett's esophagus.[3]

References

  1. ^ "Porfimer injection Prescribing information" (PDF). 
  2. ^ a b c d "Photodynamic Therapy (PDT) for Lung Cancers". 2006. 
  3. ^ "FDA Patient Safety News: Show #20, October 2003". October 2003. Retrieved 2009-08-17. 

External links

  • Photofrin
  • Photofrin marketing info
  • Side effects of PDT with Photofrin
  • History of Photofrin
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.